Companies / Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc.
Nasdaq: VRDNCIK 1590750WALTHAM, MA
Financials · FY2017
Ownership
113.3M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.05% | 57,636 |
| 10%+ / strategic | 8.93% | 10,120,350 |
| Institutions | 89.92% | 101,875,279 |
| Public float | 1.09% | 1,239,004 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Mahoney Stephen F.CEOPresident and CEO · Director | 0.03% | 33,130 |
Beetham Thomas W.Chief Operating Officer | 0.01% | 13,271 |
Harmon SethChief Financial Officer | <0.01% | 7,790 |
Tousignant JenniferChief Legal Officer | <0.01% | 3,445 |
Tripuraneni RadhikaChief Medical Officer | — | — |
Institutional holders 238
View all →| Holder | Value | % of shares |
|---|---|---|
| $447.64M | 12.70% | |
| $174.65M | 4.95% | |
| $157.09M | 7.55% | |
| $135.64M | 3.85% | |
| $121.82M | 3.46% | |
| $120.83M | 3.43% | |
| $112.52M | 5.41% | |
| $78.57M | 2.23% | |
| $61.35M | 1.74% | |
| $55.46M | 1.57% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $48.84M | +2.7M +76.69% | 6,124,976 5.41% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $38.94M | +2.1M +32.95% | 8,551,488 7.55% of shares | medium |
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | Trim | Common stock | $-36.61M | -1.9M -61.52% | 1,170,829 1.03% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Add | Common stock | $35.44M | +1.8M +359.64% | 2,315,957 2.04% of shares | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common stock | $23.16M | +744K +302.88% | 990,117 0.87% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Trim | Common stock | $-21.64M | -1.1M -80.40% | 269,587 0.24% of shares | medium |
| Q2 2026 as of | Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 13F manager | Exit | Common stock | $-13.17M | -423K -100.00% | 0 | medium |
| Q1 2026 as of | Novo Holdings A/S 13F manager | Trim | Common stock | $-7.43M | -380K -15.97% | 2,000,000 1.77% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| State Street Corporation | Passive13G | — |
| Vanguard Group Inc | Passive13G/A | — |
| Deep Track Capital, LP | Passive13G/A | — |
| Kynam Capital Management, LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VRDN | — | 92790C104 |